Human medicines European public assessment report (EPAR): Procysbi, mercaptamine, Date of authorisation: 05/09/2013, Revision: 17, Status: Authorised

Human medicines European public assessment report (EPAR): Procysbi, mercaptamine, Date of authorisation: 05/09/2013, Revision: 17, Status: Authorised

Human medicines European public assessment report (EPAR): Lopinavir/Ritonavir Viatris (previously Ritonavir Mylan), lopinavir,ritonavir, Date of authorisation: 14/01/2016, Revision: 22, Status: Authorised

Human medicines European public assessment report (EPAR): Lopinavir/Ritonavir Viatris (previously Ritonavir Mylan), lopinavir,ritonavir, Date of authorisation: 14/01/2016, Revision: 22, Status: Authorised

Human medicines European public assessment report (EPAR): Nevanac, nepafenac, Date of authorisation: 11/12/2007, Revision: 20, Status: Authorised

Human medicines European public assessment report (EPAR): Nevanac, nepafenac, Date of authorisation: 11/12/2007, Revision: 20, Status: Authorised

Human medicines European public assessment report (EPAR): Eksunbi, ustekinumab, Date of authorisation: 12/09/2024, Revision: 2, Status: Withdrawn

Human medicines European public assessment report (EPAR): Eksunbi, ustekinumab, Date of authorisation: 12/09/2024, Revision: 2, Status: Withdrawn

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

randomness